Chen CS - Search Results

1

From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.

Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw YJ, Kulp SK, Chen CS. Zhu J, et al. Among authors: chen cs. Cancer Res. 2004 Jun 15;64(12):4309-18. doi: 10.1158/0008-5472.CAN-03-4063. Cancer Res. 2004. PMID: 15205346

2

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.

Song X, Lin HP, Johnson AJ, Tseng PH, Yang YT, Kulp SK, Chen CS. Song X, et al. Among authors: chen cs. J Natl Cancer Inst. 2002 Apr 17;94(8):585-91. doi: 10.1093/jnci/94.8.585. J Natl Cancer Inst. 2002. PMID: 11959891

3

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.

Zhu J, Song X, Lin HP, Young DC, Yan S, Marquez VE, Chen CS. Zhu J, et al. Among authors: chen cs. J Natl Cancer Inst. 2002 Dec 4;94(23):1745-57. doi: 10.1093/jnci/94.23.1745. J Natl Cancer Inst. 2002. PMID: 12464646

4

Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.

Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS. Yang CC, et al. Among authors: chen cs. J Biol Chem. 2003 Jul 11;278(28):25872-8. doi: 10.1074/jbc.M301744200. Epub 2003 May 8. J Biol Chem. 2003. PMID: 12738789 Free article.

5

3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.

Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ, Chen CS. Kulp SK, et al. Among authors: chen cs, chen kf. Cancer Res. 2004 Feb 15;64(4):1444-51. doi: 10.1158/0008-5472.can-03-2396. Cancer Res. 2004. PMID: 14973075

6

Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation.

Shaw YJ, Yang YT, Garrison JB, Kyprianou N, Chen CS. Shaw YJ, et al. Among authors: chen cs. J Med Chem. 2004 Aug 26;47(18):4453-62. doi: 10.1021/jm049752k. J Med Chem. 2004. PMID: 15317457

7

Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.

Ding H, Han C, Zhu J, Chen CS, D'Ambrosio SM. Ding H, et al. Among authors: chen cs. Int J Cancer. 2005 Feb 20;113(5):803-10. doi: 10.1002/ijc.20639. Int J Cancer. 2005. PMID: 15499625

8

Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms.

Lin HP, Kulp SK, Tseng PH, Yang YT, Yang CC, Chen CS, Chen CS. Lin HP, et al. Among authors: chen cs. Mol Cancer Ther. 2004 Dec;3(12):1671-80. Mol Cancer Ther. 2004. PMID: 15634661

9

Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.

Tseng PH, Lin HP, Zhu J, Chen KF, Hade EM, Young DC, Byrd JC, Grever M, Johnson K, Druker BJ, Chen CS. Tseng PH, et al. Among authors: chen cs, chen kf. Blood. 2005 May 15;105(10):4021-7. doi: 10.1182/blood-2004-07-2967. Epub 2005 Jan 21. Blood. 2005. PMID: 15665113 Free PMC article.

10

Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.

Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS. Shiau CW, et al. Among authors: chen cs, chen kf. Cancer Res. 2005 Feb 15;65(4):1561-9. doi: 10.1158/0008-5472.CAN-04-1677. Cancer Res. 2005. PMID: 15735046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,457 results

Search Page

Filters